NCT04143646Active, not recruiting
New Technologies for Intensive Prevention Programs - NET-IPP
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
In a randomized trial patients hospitalized for myocardial infarction are prospectively enrolled and assigned to either a web-based intensive prevention program or usual care (1 : 1 randomization). The web-based program includes telemetric transmission of data on cardiocascular risk factors (physical activity, blood pressure, body weight) by patients to the study center, e-learning modules by the study center and repetitive electronic contacts by e-mails and apps between a prevention assistant and the patient. In addition, genetic risk on cardiovascular events will be assessed in all patients of the intervention group by a polygenetic risk score (PRS). Patients of the intervention group are randomly assigned to disclosure of genetic risk vs. no disclosure. The study hypothesis is that disclosure of genetic risk improves cardiovascular risk factor control by increased patient motivation.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 864 (actual)
- First submitted
- 23 Oct 2019
- Start date
- 1 May 2020
- Primary completion date
- 30 Oct 2026
- Lead sponsor
- Herzzentrum Bremen
- Diseases
- Coronary artery disease
- NCT number
- NCT04143646
What you commit to
- Study type: Interventional
- Participants enrolled: 864
- From 1 May 2020 to the primary completion date, 30 Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Chronic drug and alcohol abuse
Other illness
- Hemodynamically significant valvular heart disease
- Exercise limitations due to clinical conditions not related to CAD (such as severe orthopedic disorders,..)
Age
- Any major non-cardiac condition that would adversely affect survival during the duration of the study (such as cancer with prognosis \< 2 years,..)
Other
- Patient refusal or inability to give informed consent
- Inability to cooperate with the protocol, including longterm follow-up
Who the study is looking for
- Hospitalization due to acute myocardial infarction (ST-elevation or non-ST-elevation myocardial infarction) defined according to valid international guidelines
- Access to internet and consent to participate in a web-based prevention program
- Consent for genetic risk assessment for cardiovascular events and risk disclosure according to randomization
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Herzzentrum Bremen Coordinator of this site? Confirm its status | Bremen | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.